Advertisement

Journal of Endocrinological Investigation

, Volume 9, Issue 4, pp 341–347 | Cite as

The endocrine effects of ketoconazole

  • Nicoletta Sonino
Review Article

Key-words

Ketoconazole steroid inhibitors steroidogenesis prostate cancer Cushing’s syndrome androgens cortisol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Graybill J.R., Drutz D.J. Ketoconazole: a major innovation for treatment of fungal disease. Ann. Intern. Med. 93: 921, 1980.PubMedCrossRefGoogle Scholar
  2. 2.
    Borgers M., Van den Bossche H., De Brabander M. The mechanism of action of the new antimycotic ketoconazole. Am. J. Med. 74: 2, 1983.PubMedCrossRefGoogle Scholar
  3. 3.
    Thienpont D., Van Custem J., Van Gerven F., Heeres J., Janssen P.A.J. Ketoconazole- a new broad spectrum orally active antimycotic. Experientia 35: 606, 1979.PubMedCrossRefGoogle Scholar
  4. 4.
    Dixon D., Shadomy S., Shadomy H.J., Espinel-Ingroff A., Kerkering T.M. Comparison of the in vitro antifungal activities of miconazole and a new imidazole R41, 400. J. Infect. Dis. 138: 245, 1978.PubMedCrossRefGoogle Scholar
  5. 5.
    Borelli D., Fuentes J., Leiderman E., Restrepo A., Bran J.L., Legendre R., Levine H.B., Stevens D.A. Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs. Postgrad. Med. J. 55: 657, 1979.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Van den Bossche H., Willemnsens G., Cools W., Cornelissens F., Lauwers W., Cutsen J. In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis. Antimicrob. Agents Chemother. 17: 922, 1980.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Buttke T.M., Chapman S.T. Inhibition by ketoconazole of mitogen-induced DNA synthesis and cholesterol biosynthesis in lymphocytes. Antimicrob. Agents Chemother. 24: 478, 1983.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    De Felice P., Johnson D.G., Galgiani J.N. Gynecomastia with ketoconazole. Antimicrob. Agents Chemother. 19: 1073, 1981.CrossRefGoogle Scholar
  9. 9.
    Stevens D.A., Stiller R.L., Williams P.L., Sugar A.M. Experience with ketoconazole in three major manifestations of progressive coccidiomycosis. Am. J. Med. 74: 58, 1983.PubMedCrossRefGoogle Scholar
  10. 10.
    Pont A., Williams P.L., Azhar S., Reitz R.E., Bochra C., Smith E.R., Stevens D.A. Ketoconazole blocks testosterone synthesis. Arch. Intern. Med. 142: 2137, 1982.PubMedCrossRefGoogle Scholar
  11. 11.
    Pont A., Williams P.L., Loose D.S., Feldman D., Reitz R.E., Bochra C., Stevens D.A. Ketoconazole blocks adrenal steroid synthesis. Ann. Intern. Med. 97: 370, 1982.PubMedCrossRefGoogle Scholar
  12. 12.
    Stevens D.A. Ketoconazole metamorphosis- An antimicrobial becomes an endocrine drug. Arch. Intern. Med. 145: 813, 1985.PubMedCrossRefGoogle Scholar
  13. 13.
    Trachtenberg J., Pont A. Ketoconazole therapy for advanced prostate cancer. Lancet 2: 433, 1984.PubMedCrossRefGoogle Scholar
  14. 14.
    Miettinen T.A., Valtonen V.V. Ketoconazole and cholesterol synthesis. Lancet 2: 1271, 1984.PubMedCrossRefGoogle Scholar
  15. 15.
    Kraemer F.B., Pont A. Inhibition of cholesterol synthesis by ketoconazole. Am. J. Med. 80: 616, 1986.PubMedCrossRefGoogle Scholar
  16. 16.
    Schurmeyer Th., Nieschlag E. Effect of ketoconazole and other imidazole fungicides on testosterone biosynthesis. Acta Endocrinol. (Kbh.) 105: 275, 1984.Google Scholar
  17. 17.
    De Coster R., Beerens D., Dom J., Williemsens G. Endocrinological effects of single daily ketoconazole administration in male beagle dogs. Acta Endocrinol. (Kbh.) 107: 275, 1984.Google Scholar
  18. 18.
    Pont A., Graybill J.R., Craven P.C., Galgiani J.N., Dismukes W.E., Reitz R.E., Stevens D.A. High-dose ketoconazole therapy and adrenal and testicular function in humans. Arch. Intern. Med. 144: 2150, 1984.PubMedCrossRefGoogle Scholar
  19. 19.
    Van den Bossche H., Lawers W., Williemsens G., Cools W. Ketoconazole an inhibitor of the cytochrome P-450 dependent testosterone biosynthesis. Prog. Clin. Biol. Res. 185A: 187, 1985.Google Scholar
  20. 20.
    Van den Bossche H., Lawers W., Williemsens G., Cools W. The cytochrome P-450 dependent C 17–20 lyase in subcellular fractions of the rat testis: differences in sensitivity to ketoconazole and itraconazole. In: Boobis A.R., Caldwell J., De Matteis F., Elcombe C.R. (Eds.), Microsome and drug oxidations. Taylor and Francis, London, 1985, p. 63.Google Scholar
  21. 21.
    Van den Bossche H., Williemsens G., Cools W., Bellens D. Molecular basis for ketoconazole’s antifungal and antiandrogen activities. J. Steroid Biochem. 23 (Suppl.): 36S (Abstract), 19??.CrossRefGoogle Scholar
  22. 22.
    Sikka S.C., Swerdloff R.S., Rajfer J. In vitro inhibition of testosterone biosynthesis by ketoconazole. Endocrinology 116: 1920, 1985.PubMedCrossRefGoogle Scholar
  23. 23.
    Santen R.J., Van den Bossche H., Symoens J., Brugmand J., De Coster R. Sites of action of low dose ketoconazole on androgen biosynthesis in men. J. Clin. Endocrinol. Metab. 57: 732, 1983.PubMedCrossRefGoogle Scholar
  24. 24.
    Kan P.B., Hirst M.A., Feldman D. Inhibition of steroidogenic cytochrome P-450 enzyme in rat testis by ketoconazole and related imidazole antifungal drugs. J. Steroid Biochem. 23: 1023, 1985.PubMedCrossRefGoogle Scholar
  25. 25.
    Pont A., Trachtenberg J. Hormonal changes in patients on chronic high dose ketoconazole. Clin. Res. 32: 271A, 1984.Google Scholar
  26. 26.
    Trachtenberg J. Ketoconazole therapy in advanced prostate cancer. J. Urol. 132: 61, 1984.PubMedGoogle Scholar
  27. 27.
    Contreras P., Altieri E., Liberman C., Gac A., Rojas A., Ibarra A., Ravanal M., Seron-Ferre M. Adrenal rest tumor of the liver causing Cushing’s syndrome: treatment with ketoconazole preceding an apparent surgical cure. J. Clin. Endocrinol. Metab. 60: 21, 1985.PubMedCrossRefGoogle Scholar
  28. 28.
    Loose D.S., Kan P.B., Hirst M.A., Marcus R.A., Feldman D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P-450 dependent enzymes. J. Clin. Invest. 71: 1495, 1983.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Nagai K., Miyamory I., Ikeda M., Koshida H., Takeda R., Suhara K., Katagiri M. Effect of ketoconazole (an imidazole antimycotic agent) and other inhibitors of steroidogenesis on cytochrome P-450-catalyzed reactions. J. Steroid Biochem. 24: 321, 1986.PubMedCrossRefGoogle Scholar
  30. 30.
    Kowal J. The effect of ketoconazole on steroidogenesis in cultured mouse adrenal cortex tumor cells. Endocrinology 112: 1541, 1983.PubMedCrossRefGoogle Scholar
  31. 31.
    Engelhardt D., Dorr G., Jaspers Ch., Knorr D. Ketoconazole blocks Cortisol secretion in man by inhibition of adrenal 11 beta-hydroxylase. Klin. Wochenschr. 63: 607, 1985.PubMedCrossRefGoogle Scholar
  32. 32.
    Henry H.L. Effect of ketoconazole and iconazole on 25-hydroxy-vitamin D3 metabolism by cultured chick kidney cells. J. Steroid Biochem. 23: 991, 1985.PubMedCrossRefGoogle Scholar
  33. 33.
    Mosca P., Benazzi P., Novelli G., Jezequel A.M., Orlandi F. In vivo and in vitro inhibition of hepatic microsomal drug metabolism by ketoconazole. Br. J. Exp. Pathol. 66: 737, 1985.PubMedCentralPubMedGoogle Scholar
  34. 34.
    Brown M.W., Maldonado A.L., Meredith C.G., Speeg K.V. Effect of ketoconazole on hepatic oxidative drug metabolism. Clin. Pharmacol. Ther. 37: 290, 1985.PubMedCrossRefGoogle Scholar
  35. 35.
    Loose D.S., Stover P., Feldman D. Ketoconazole binds to glucocorticoid antagonist activity in cultured cells. J. Clin. Invest. 72: 404, 1983.PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Grosso D.S., Boyden T.W., Pamenter R.W., Johnson D.G., Stevens D.A., Galgiani J.N. Ketoconazole inhibition of testicular secretion of testosterone and displacement of steroid hormones from serum transport protein. Antimicrob. Agents Chemother. 23: 207, 1983.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Pont A., Goldman E.S., Sugar A.M., Siiteri P.K., Stevens D.A. Ketoconazole-induced increase in estradiol-testosterone ratio. Arch. Intern. Med. 145: 1429, 1985.PubMedCrossRefGoogle Scholar
  38. 38.
    Burrin J.M., Yeo T.H., Ashby M.J., Bloom S.R. Effect of ketoconazole on adrenocorticotrophic hormone secretion in vitro and in vivo. J. Endocrinol. 108: 37, 1986.PubMedCrossRefGoogle Scholar
  39. 39.
    Bhasin S., Sikka S., Fielder T., Sod-Moriah U., Levine H.B., Swerdloff R.S., Rajfer J. Hormonal effects of ketoconazole in vivo in the male rat: mechanism of action. Endocrinology 118: 1229, 1986.PubMedCrossRefGoogle Scholar
  40. 40.
    Stalla G.K., Stalla J., Losa M., Muller O.A., von Werder K. Ketoconazole inhibits ACTH secretion in vitro. Program and Abstracts of the 68th Annual Meeting of the Endocrine Society, Anaheim, 1986 (Abstract 650).Google Scholar
  41. 41.
    Daneshmend T.K., Warnock D.W., Turner A., Robert C.J.C. Pharmacokinetics of ketoconazole in normal subjects. J. Antimicrob. Chemother. 8: 299, 1981.PubMedCrossRefGoogle Scholar
  42. 42.
    Heel R.C., Brogden R.N., Carmine A., Morley P.A., Speight T.M., Avery G.S. Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs 23: 1, 1982.PubMedCrossRefGoogle Scholar
  43. 43.
    Van Tyle J.H. Ketoconazole: Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy 4: 343, 1984.PubMedGoogle Scholar
  44. 44.
    Brass C., Galgiani J.N., Blaschke T.F., De Felice R., O’Reilly R.A., Stevens D.A. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob. Agents Chemother. 21: 151, 1982.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Van der Meer J.W.M., Keuning J.J., Scheijgrond H.W., Heykants J., van Cutsem J., Brugmans J. The influence of gastric acidity on the bio-availability of ketoconazole. J. Antimicrob. Chemother. 6: 552, 1980.CrossRefGoogle Scholar
  46. 46.
    Lewis J.H., Zimmerman H.J., Benson G.D., Ishak K.G. Hepatic injury associated with ketoconazole therapy. Gastroenterology 86: 503, 1984.PubMedGoogle Scholar
  47. 47.
    Macnair A.L., Gascoigne E., Heap J., Schuermans V., Symoens J. Hepatitis and ketoconazole therapy. Br. Med. J. 283: 1058, 1981.CrossRefGoogle Scholar
  48. 48.
    Duarte P.A., Chow C.C., Simmons F., Ruskin J. Fatal hepatitis associated with ketoconazole therapy. Arch. Intern. Med. 144: 1069, 1984.PubMedCrossRefGoogle Scholar
  49. 49.
    van Dijke C.P.H., Veerman F.R., Haverkamp H.C. Anaphylactic reactions to ketoconazole. Br. Med. J. 287: 1673, 1983.CrossRefGoogle Scholar
  50. 50.
    Vawda A.I., Davies A.G. An investigation into the effect of ketoconazole on testicular function in Wistar rats. Acta Endocrinol. (Kbh.) 111: 246, 1986.Google Scholar
  51. 51.
    Tucker W.S. Jr., Snell B.B., Island D.P., Gregg C.R. Reversible adrenal insufficiency induced by ketoconazole. JAMA 253: 2413, 1985.PubMedCrossRefGoogle Scholar
  52. 52.
    White M.C., Kendall-Tylor P. Adrenal hypofunction in patients taking ketoconazole. Lancet 1: 44, 1985.PubMedCrossRefGoogle Scholar
  53. 53.
    Pillans P.I., Cowan P., Whitelaw D. Hyponatremia and confusion in a patient taking ketoconazole. Lancet 1: 821, 1985.PubMedCrossRefGoogle Scholar
  54. 54.
    Trachtenberg J., Halpern N., Pont A. Ketoconazole: a novel and rapid treatment for advanced prostate cancer. J. Urol. 130: 152, 1983.PubMedGoogle Scholar
  55. 55.
    Heyns W., Drochmans A., van der Schueren E., Verhoeven G. Endocrine effects of high-dose ketoconazole therapy in advanced prostate cancer. Acta Endocrinol. (Kbh.) 110: 276, 1985.Google Scholar
  56. 56.
    Denis L., Chaban M., Mahler Ch. Clinical applications of ketoconazole in prostatic cancer. Prog. Clin. Biol. Res. 185A: 319, 1985.PubMedGoogle Scholar
  57. 57.
    Williams G. Ketoconazole for prostate cancer. Lancet 2: 696, 1984.PubMedCrossRefGoogle Scholar
  58. 58.
    Waxman J. Hormonal aspects of prostatic cancer: a review. J. Res. Soc. Med. 78: 129, 1985.Google Scholar
  59. 59.
    English H.F., Santner S.J., Levine H.B., Santen R.J. Inhibition of testosterone production with ketoconazole alone and in combination with a gonadotropin releasing hormone analogue in the rat. Cancer Res. 46: 38, 1986.PubMedGoogle Scholar
  60. 60.
    Holland F.J., Fishman L., Bailey J.D., Fazekas A.T.A. Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy. N. Engl. J. Med. 312: 1023, 1985.PubMedCrossRefGoogle Scholar
  61. 61.
    Contreras P., Rojas A., Biagini L., Gonzales P., Massardo T. Regression of metastatic adrenal carcinoma during palliative ketoconazole treatment. Lancet 2: 151, 1985.PubMedCrossRefGoogle Scholar
  62. 62.
    Sonino N., Boscaro M., Merola G., Mantero F. Prolonged treatment of Cushing’s disease by ketoconazole. J. Clin. Endocrinol. Metab. 61: 718, 1985.PubMedCrossRefGoogle Scholar
  63. 63.
    Carvalho D., Pignatelli D., Resende C. Ketoconazole for hirsutism. Lancet 2: 560, 1985.PubMedCrossRefGoogle Scholar
  64. 64.
    Namer M., Khater R., Frenay M., Boublil J.L. High dose of ketoconazole in the treatment of advanced breast cancers. Bull. Cancer 73: 89, 1986.PubMedGoogle Scholar
  65. 65.
    Bradbrook I.D., Gillies H.C., Morrison P.J., Robinson J., Rogers HJ., Spector R.G. Effects of single and multiple doses of ketoconazole on adrenal function in normal subjects. Br. J. Clin. Pharmacol. 20: 163, 1985.PubMedCentralPubMedCrossRefGoogle Scholar
  66. 66.
    Engelhardt D., Mann K., Hormann R., Braun S., Karl H.J. Ketoconazole inhibits Cortisol secretion of an adrenal adenoma in vivo and in vitro. Klin. Wochenschr. 61: 373, 1983.PubMedCrossRefGoogle Scholar
  67. 67.
    Engelhardt D., Mann K., Hormann R., Braun S., Karl H.J. The influence of ketoconazole on Cortisol secretion in Cushing’s syndrome. In vivo and in vitro studies in six patients. Acta Endocrinol. (Kbh.) (Suppl.) 265: 281, 1983 (Abstract).Google Scholar
  68. 68.
    Contreras P., Rojas A., Costamaillere L., Michelsen H., Pumarino H., Arteaga E. Endocrine effects of ketoconazole administration in 10 patients with Cushing’s syndrome. Program and Abstracts of the 67th Annual Meeting of the Endocrine Society, Baltimore 1985 (Abstract 550).Google Scholar
  69. 69.
    Shepherd F.A., Hoffert B., Evans W.K., Emery G., Trachtenberg J. Ketoconazole. Use in the treatment of ectopic adrenocorticotropic hormone production and Cushing’s syndrome in small-cell lung cancer. Arch. Intern. Med. 145: 863, 1985.PubMedCrossRefGoogle Scholar
  70. 70.
    Angeli A., Frairia R. Ketoconazole therapy in Cushing’s disease. Lancet 1: 821, 1985.PubMedCrossRefGoogle Scholar
  71. 71.
    Sonino N., Boscaro M., Ambroso G., Merola G., Mantero F. Prolonged treatment of Cushing’s disease by metyrapone and aminoglutethimide. IRCS Med. Sci. 14: 485, 1986.Google Scholar
  72. 72.
    Sonino N., Merola G. The use of steroid inhibitors in the management of patients. In: Agarwal M.K. (Ed.), Adrenal steroid antagonism. De Gruyter, Berlin and New York, 1984, p. 341.Google Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1986

Authors and Affiliations

  • Nicoletta Sonino
    • 1
    • 2
  1. 1.Istituto di Semeiotica MedicaUniversity of PadovaPadovaItaly
  2. 2.Department of BiochemistryState University of New York at BuffaloBuffaloUSA

Personalised recommendations